NovAccel is a startup dedicated to the development of manufacturing technologies for medical radioactive isotopes, aiming to enable the practical application of next-generation cancer therapies such as Targeted Alpha Therapy (TAT).
TAT is a promising treatment modality that delivers highly potent alpha radiation emitted from drugs selectively accumulated in cancer cells, offering strong therapeutic efficacy. However, a global shortage of its key radioactive isotope, Actinium-225 (Ac-225), has become a major bottleneck to its widespread adoption.
NovAccel’s compact superconducting accelerator, designed at a scale of approximately 10 meters, combines small size with high efficiency, enabling a more stable and scalable supply of Ac-225 compared to conventional production methods.
Through this approach, NovAccel aims to establish a sustainable supply system that supports the entire value chain, from drug development to clinical application.
TAT is a promising treatment modality that delivers highly potent alpha radiation emitted from drugs selectively accumulated in cancer cells, offering strong therapeutic efficacy. However, a global shortage of its key radioactive isotope, Actinium-225 (Ac-225), has become a major bottleneck to its widespread adoption.
NovAccel’s compact superconducting accelerator, designed at a scale of approximately 10 meters, combines small size with high efficiency, enabling a more stable and scalable supply of Ac-225 compared to conventional production methods.
Through this approach, NovAccel aims to establish a sustainable supply system that supports the entire value chain, from drug development to clinical application.
Investors 1
| Date | Name | Website |
| 10.07.2026 | The Univer... | ut-ec.co.j... |
Mentions in press and media 1
| Date | Title | Description |
| - | NovAccel | “NovAccel is a company that manufactures and sells radioisotopes such as actinium・225, which are attracting attention in the future cancer treatment, utilizing its experience and technology related to superconducting accelerators.” |